NO160782C - Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre.

Info

Publication number
NO160782C
NO160782C NO834093A NO834093A NO160782C NO 160782 C NO160782 C NO 160782C NO 834093 A NO834093 A NO 834093A NO 834093 A NO834093 A NO 834093A NO 160782 C NO160782 C NO 160782C
Authority
NO
Norway
Prior art keywords
benzo
dihydro
oxo
dimethyl
kinolizin
Prior art date
Application number
NO834093A
Other languages
English (en)
Norwegian (no)
Other versions
NO834093L (no
NO160782B (no
Inventor
Richard Mark Stern
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of NO834093L publication Critical patent/NO834093L/no
Priority to NO883544A priority Critical patent/NO168101C/no
Priority to NO883546A priority patent/NO168102C/no
Priority to NO883545A priority patent/NO883545D0/no
Publication of NO160782B publication Critical patent/NO160782B/no
Publication of NO160782C publication Critical patent/NO160782C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Quinoline Compounds (AREA)
NO834093A 1982-11-12 1983-11-09 Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre. NO160782C (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO883544A NO168101C (no) 1982-11-12 1988-08-10 6-fluor-5-methyl-1,2,3,4-tetrahydrokinaldin for anvendelse som utgangsmateriale ved fremstilling av terapeutisk aktive forbindelser
NO883546A NO168102C (no) 1982-11-12 1988-08-10 5-carboxyl-6-fluorkinaldin for anvendelse som utgangsmateriale ved fremstilling av terapeutisk aktive forbindelser
NO883545A NO883545D0 (no) 1982-11-12 1988-08-10 Diethyl-2-(n-(6-fluor-5-methyl-1,2,3,4-tetra-hydrokinaldinyl))-methylenmalonat for anvendelse som utgangsmateriale ved fremstilling av terapeutisk aktive forbindelser.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/441,245 US4472405A (en) 1982-11-12 1982-11-12 Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives

Publications (3)

Publication Number Publication Date
NO834093L NO834093L (no) 1984-05-14
NO160782B NO160782B (no) 1989-02-20
NO160782C true NO160782C (no) 1989-05-31

Family

ID=23752110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834093A NO160782C (no) 1982-11-12 1983-11-09 Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre.

Country Status (22)

Country Link
US (1) US4472405A (fr)
EP (1) EP0109284B1 (fr)
JP (1) JPH0826017B2 (fr)
KR (1) KR890000864B1 (fr)
AT (1) ATE39926T1 (fr)
AU (1) AU568319B2 (fr)
CA (2) CA1254568A (fr)
CS (1) CS390391A3 (fr)
DE (1) DE3378912D1 (fr)
EG (1) EG16492A (fr)
ES (1) ES8504727A1 (fr)
FI (1) FI73213C (fr)
GR (1) GR79402B (fr)
IE (1) IE56232B1 (fr)
IL (1) IL70198A (fr)
IN (1) IN161391B (fr)
MX (1) MX7314E (fr)
NO (1) NO160782C (fr)
NZ (1) NZ206233A (fr)
OA (1) OA07586A (fr)
PT (1) PT77649B (fr)
ZA (1) ZA838436B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519926A1 (de) * 1985-06-04 1986-12-04 Bayer Ag Indolinderivate, verfahren zu ihrer herstellung und diese indolinderivate enthaltende kosmetische lichtschutzmittel
US4898945A (en) * 1986-01-22 1990-02-06 Minnesota Mining And Manufacturing Company Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid
CA1302413C (fr) * 1986-01-22 1992-06-02 Bruce E. Williams Procede pour la preparation de l'acide 6,7-dihydro-5,8-dimethyl-9-fuloro-1-oxo-1h, 5h-benzo[i,j]quinolizine-2-carboxylique
GB9827865D0 (en) * 1998-12-18 1999-02-10 Woodcock Fiona Medicament
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
CA2814082A1 (fr) 2010-10-12 2012-04-19 Bayer Intellectual Property Gmbh Comprimes mastiquables mous non a base d'amidon
UA118748C2 (uk) 2012-12-19 2019-03-11 Байєр Енімал Хелс Гмбх Таблетки, що мають покращене сприйняття та хорошу стабільність при зберіганні
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
EP4025220A4 (fr) * 2019-09-06 2023-10-04 Elanco US Inc. Compositions vétérinaires granulaires de goût agréable

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA728444B (en) * 1971-12-30 1973-10-31 Riker Laboratories Inc Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS5655388A (en) 1979-10-11 1981-05-15 Otsuka Pharmaceut Co Ltd Benzo ij quinolidine-2-carboxylic acid derivative, and its preparation
US4301289A (en) * 1980-02-19 1981-11-17 Minnesota Mining And Manufacturing Company Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid
JPS59155381A (ja) * 1983-02-22 1984-09-04 Kyorin Pharmaceut Co Ltd ベンゾキノリジンカルボン酸誘導体及びその製造法

Also Published As

Publication number Publication date
NZ206233A (en) 1986-10-08
CA1254568A (fr) 1989-05-23
FI834147A0 (fi) 1983-11-11
ES527163A0 (es) 1985-05-01
DE3378912D1 (de) 1989-02-16
IL70198A0 (en) 1984-02-29
AU2118183A (en) 1984-05-17
EG16492A (en) 1994-11-30
FI73213B (fi) 1987-05-29
IE56232B1 (en) 1991-05-22
KR890000864B1 (ko) 1989-04-11
FI73213C (fi) 1987-09-10
EP0109284A1 (fr) 1984-05-23
EP0109284B1 (fr) 1989-01-11
IE832639L (en) 1984-05-12
MX7314E (es) 1988-05-11
IL70198A (en) 1988-11-15
IN161391B (fr) 1987-11-28
ATE39926T1 (de) 1989-01-15
PT77649B (en) 1986-03-19
FI834147A (fi) 1984-05-13
PT77649A (en) 1983-12-01
KR840006659A (ko) 1984-12-01
NO834093L (no) 1984-05-14
NO160782B (no) 1989-02-20
ZA838436B (en) 1985-06-26
US4472405A (en) 1984-09-18
GR79402B (fr) 1984-10-22
JPH0826017B2 (ja) 1996-03-13
OA07586A (fr) 1985-03-31
AU568319B2 (en) 1987-12-24
CS390391A3 (en) 1992-09-16
CA1280755C (fr) 1991-02-26
ES8504727A1 (es) 1985-05-01
JPS59112969A (ja) 1984-06-29

Similar Documents

Publication Publication Date Title
NO160782C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre.
NO173238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
NO173547C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater
NO171214C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater
NO152005C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
IE38302B1 (en) Aromatic hydroxy amines
NO301372B1 (no) Fremgangsmåte for fremstilling av et farmasöytisk tålbart salt av klavulansyre
ES8702405A1 (es) Procedimiento para la obtencion de acidos benzo(ij) quinolizina-2-carboxilicos y sus derivados
NO157330C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 3-metylflavon-8-karboksylsyreestere.
IT7850230A0 (it) Derivati di alfa-alogenometilammino acidi ad attivita' farmaceutica eprocedimento per la loro preparazione
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
IT8024165A0 (it) Esteri di acidi dialogenovinilciclopropancarbossili ci, procedimento per la loro preparazione e loro impiego per combattere organismi nocivi e anche alcooli alfa-alogenoetinil-3-fenossi-benzilici.
IT1101667B (it) Esteri 3-fenossi-alfa-vinil-benzilici di acidi vinil-ciclopropan-carbossilici, procedimento per la loro preparatione e loro impiego per combattere organismi nocivi
NO163133C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 5r, 6s, 8r-6-(1-hydroxyethyl)-2-(2-carbamoyloxy-ethylthio)-penem-3-carboxylsyre.
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
SE8301687L (sv) 8-cyano-6,7-dihydro-5-metyl-1-oxo-1h-,5h-benso(ij)kinolizin-2-karboxylsyror och forfarande for framstellning derav
DK550183A (da) 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo/ij/-quinolizin-2-carboxylsyre, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved udoevelse af fremgangsmaaden
DE3461464D1 (en) Derivatives of d-2-(6-methoxy-2-naphthyl)-propionic acid having therapeutical activity, process for their preparation and pharmaceutical compositions containing them
HUT60736A (en) Process for producing derivatives of 3-l-(5-thioxo-l-prolyl)-thiazolidine-4-carboxylic acid and pharmaceutical compositions comprising same as active ingredient
JPS52148042A (en) New derivative of 33*3*55dichlorophenyl**ureido acetic acid and process for manufacture thereof and germicide containing said derivative as active ingredient
NO850154L (no) Fremgangsmaate ved fremstilling av nye terapeutisk aktive karboksylsyrederivater
IT8048019A0 (it) Procedimento per la preparazione di esteri di acidi carbossilici dotati di attivita' pesticida
NO165396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere.
GB2011887A (en) Antiallergic agent